Richard Carter, PhD
Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson
February 2015 – Present (2 years 7 months)
Serve as a cell biologist in immunological assay group within Lead Optimization, a fast-paced R&D environment supporting Oncology and Infectious Disease large molecule and biologics programs.
Design and develop methods to establish proof-of-concept and mechanism of action for candidate lead molecules throughout phases of early discovery. Perform primary immune cell based assays. Considered resident expert in imaging flow cytometry analysis and immunological assays.
Leverage comprehensive knowledge and diverse skill set to originate research strategy and support critical path decisions. Interact cross functionally with internal and external collaborators, and communicate relevant data and conclusions to department-wide audiences.
News 
Market Data 
Discover 
